By Early Investing on March 18, 2019
In our first-ever Behind the Pick, we take you behind the scenes to learn more about why Andy Gordon recommended HyperSciences.
By Andy Gordon on February 11, 2019
This week, we’re checking in with two of our portfolio companies. HyperSciences is planning a big field test of its technology, while 20/20 GeneSystems is expanding its reach.